Aurinia Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Good morning and welcome to the 2020 Aurinia Pharmaceuticals Inc. Annual General and Special Meeting. The meeting will now come to order. My name is Peter Greenleaf, and I'm the President and Chief Executive Officer of the corporation. Pursuant to the bylaws of the corporation, I will be acting as the Chairman of the meeting.
As you know, we took the initiative to move to a virtual format for our Annual General Meeting this year in response to the COVID-19 global pandemic to ensure the health and safety of our shareholders, our employees and the general community.
In addition to tabling our financial statements, there are 8 motions that we will be voting on today. Once all of the motions have been voted on, we will announce our preliminary voting results, and the business of the meeting will officially come to a close.
I will ask Stephen Robertson, our Corporate Secretary of the company, to act as secretary for this meeting, and I will ask Kyle Gould of Computershare Investor Services Inc. to act
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |